Noscendo – tHe company
About us
Noscendo GmbH is the leading global provider of software-based pathogen identification technology. We’ve made it our objective to revolutionise infection diagnostics, thus saving patient lives.
Scores of well-known university hospitals, major regional hospitals and hospital groups are already using DISQVER. We also work with several health insurance providers.
We have already received a host of awards for our pioneering approach. Noscendo was named Health-i Pioneer 2020 by Handelsblatt and Techniker Krankenkasse (TK). The award honours highly innovative ideas in the healthcare sector. In 2019, the scientific project behind DISQVER was awarded the ‘SIK Innovation Prize 2019’ by the Stuttgart Intensive Care Congress (SIK).
DISQVEr together!
Noscendo in numbers
2017
Noscendo founded
2019
Approval of DISQVER analysis platform
2
Sites, Tübingen and Duisburg
News
DigiSep trial achieves next milestone: Over 200 sepsis patients now included
About a year ago, the recruitment phase of the trial "DigiSep - Optimization of sepsis therapy based on patient-specific digital precision diagnostics" started. Now the project, led by the Department of Anesthesiology and Intensive Care Medicine at the University Hospital Essen, has reached another important
milestone: since mid-March 2023, half of the planned 410 trial patients have been recruited. Only in February, 43 patients were added, so that the recruitment target can be reached as planned in summer 2023.
DISQVER® at the annual meeting of the DGHO in Vienna: Application of NGS-based diagnostics in Haematooncology and Medical Oncology
Infections and bloodstream infections are a major cause of complications in the therapy of oncological and hematological patients. But how can the pathogens that lead to these infections be detected quickly and reliably? From 7 to 9 October, the Noscendo team will...
Noscendo presents DISQVER® at HAI 2022, the 24th Capital Congress of the DGAI for Anaesthesiology and Intensive Care Therapy
After a pandemic-related break, the 24th Capital Congress of the German Society for Anaesthesiology & Intensive Care Medicine (DGAI) will be held again this year in presence. From September 14-17, the focus will be on medical advances in anaesthesia, intensive...
Team
Dr. Jennifer Axnick
Medical Project Manager
Johannes Becher
Working student
Dr. Marcus Benz
Chief Operating Officer
Dr. Daniel borda-molina
Bioinformatician
Julia Bottlang
Team Lead Production
Christof Brass
Head of Finance
Nico Büker
Software Developer
Sebastian Clanzett
Vice President Bio & Information Technology
Dr. Frauke Diekmann
Key Account Manager
Dr. Claudia Disque-Kochem
Enabling Engineer
Irene Gil Farina
Vice President Research & Development
Michelle Fiedler
Technical Employee
Robert Fox
Team Lead Backend
Dr. Silke Grumaz
Chief Scientific Officer, Co-Founder
Dr. Peter Haug
Chief Strategy Officer, Co-Founder
Maximiliane Häußinger
Customer Success Agent
Ian Hill
Business Development Manager
Renè Hennig
Team Lead Frontend
Dr. Rafael Holzem
Quality Management Representative
Scott G. Hopkins
Sales Operations Director
Mattias Horn
Senior Solution Architect
Dr. Petra Horvatek
Customer Success Agent
Vanessa Huissel
Technician
Thomas Kästner
Head of IT Operations
Sabine Kießling-Parr
Key Account Manager
Dr. Philipp Kirstahler
Bioinformatician
Dr. Matthias Klaften
Head of Real World Evidence
Michael Klomfass
Senior IT Operator
Dr. Uta Kossatz-Böhlert
Team Lead Clinical Trials
Christina Koumourzi-Ridil
Vice President People
Silas Krug
Software Developer
Myriam Livrozet
Business Development Manager
Christian Lohmann
Head of Sales
Gabriele Magliano
Senior IT Operator
Dr. Sonia Mazitelli
Scientist
MARKUS MOOCK
Research Assistant
Dr. Andreas Moritz
Automation Scientist
Dr. Harm Müller
Key Account Manager
Ulrike Neder
Team Lead Data Analytics
Marco Pietschmann
Vice President Digital Integration
Philip Pohl
Technician
Dr. med. Klaus Rensing
Head of Medical Affairs D/A/CH
Joshua Richenhagen
Software Developer
Johannes Ristau, PhD
Senior Field Application Scientist
Benjamin Ruff
IT Technician
Jörg Schäfer
Requirements Engineer
Katja Siepmann
Accountant in Finance & Controlling
Dr. Thomas Smylla
Scientist
Franziska Stephan
Technician
Dr. Philip Stevens
Chief Executive Officer, Co-Founder
Darren Tomlinson
Vice President Marketing
Dr. Sandra Unsleber
Scientist
Frederic Vigier
Sales Business Development Manager
Maria Watters
Chief Commercial Officer
Strategic And Scientific Advisory Board
Prof. Dr. Arndt von Haeseler
Prof. von Haeseler is Head of CIBIV (Center for Integrative Bioinformatics Vienna) at the Max Perutz Labs, where he also served as the scientific director. In 2015, von Haeseler was elected as a corresponding member in Austria of the mathematics and science class of the Austrian Academy of Sciences.
Dr. Trevor Hawkins
Dr Hawkins’ 25+ year career in healthcare has included business, academic innovation and entrepreneurship. Dr Hawkins was previously Director of the Human Genome Project for the US DOE, and has held senior executive roles at Siemens Healthcare, Philips, GE Healthcare and Amersham.
Prof. Dr. James Rothman
Prof. Rothman is a highly distinguished biochemist and Sterling Professor of Cell Biology at Yale University who was awarded the 2013 Nobel Prize in Physiology/Medicine. Prof. Rothman serves, among other positions, as Chair of the Yale School of Medicine’s Department of Cell Biology and is the Director and founder of the Nanobiology Institute on Yale’s new West Campus.
Prof. Dr. Felix Wieland
Prof. Wieland is an elected Member of the Academia Europea and the National Academy of Sciences, Leopoldina, as well as an honorary member of the Charité (Medical Faculty of Humboldt University Berlin) and is a Senior Professor for Biochemistry at Heidelberg University. Prof. Wieland’s main areas of research are Enzymology, Glycobiology and Molecular Membrane Biology, including the specificity of lipid-protein interactions.
